Non-nitro radiation sensitizers.
A review of the literature on radiosensitization reveals that at least some of the non-nitro compounds, such as metabolic inhibitors and membrane-active drugs, could be considered as potentially valuable radiosensitizers for possible use in future cancer radiotherapy.
D000818:Animals; D002462:Cell Membrane / Q000187:drug effects; D003847:Deoxyglucose / Q000494:pharmacology; D003958:Diamide / Q000494:pharmacology; D004563:Electrochemistry; D004734:Energy Metabolism / Q000187:drug effects; D005033:Ethylmaleimide / Q000494:pharmacology; D005609:Free Radicals; D005947:Glucose / Q000031:analogs & derivatives / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D010100:Oxygen / Q000502:physiology; D010101:Oxygen Consumption / Q000187:drug effects; D011838:Radiation-Sensitizing Agents; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013439:Sulfhydryl Reagents / Q000494:pharmacology
D005609:Free Radicals; D011838:Radiation-Sensitizing Agents; D013438:Sulfhydryl Compounds; D013439:Sulfhydryl Reagents; D003958:Diamide; C003002:5-thio-D-glucose; D003847:Deoxyglucose; D008628:Mercury; D005947:Glucose; D005033:Ethylmaleimide; D010100:Oxygen